| 1 |
33685864 | Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial. | 2021 Apr 7 |
1 |
| 2 |
28592257 | Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction. | 2017 Jun 7 |
2 |
| 3 |
26005391 | Vitamin d in the patients with chronic kidney disease: when, to whom and in which form. | 2015 Apr |
1 |
| 4 |
26889405 | Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease. | 2012 Mar |
2 |
| 5 |
12417596 | Two novel metabolic pathways of 22-oxacalcitriol (OCT). C-25 dehydration and C-3 epimerization and biological activities of novel OCT metabolites. | 2003 Jan 17 |
2 |
| 6 |
12972708 | Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. | 2003 |
1 |
| 7 |
11799271 | 22-Oxacalcitriol upregulates p21(WAF1/Cip1) in human parathyroid glands. A preliminary report. | 2001 Nov-Dec |
1 |
| 8 |
9099905 | The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression. | 1997 Mar 14 |
1 |
| 9 |
7594646 | 22-Oxa calcitriol is a less potent regulator of keratinocyte proliferation and differentiation due to decreased cellular uptake and enhanced catabolism. | 1995 Nov |
1 |